ArticleJapanese journal of ophthalmology2026
Visual and OCT outcomes in epiretinal membrane foveoschisis with and without lamellar macular hole-related diseases.
Article in Japanese journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate changes in visual acuity and optical coherence tomography (OCT) findings after vitrectomy for epiretinal membrane foveoschisis (ERM-FS), and to compare visual and anatomical outcomes among eyes with ERM-FS alone, ERM-FS associated with macular pseudohole (MPH), and ERM-FS associated with lamellar macular hole (LMH). STUDY
designRetrospective observational study
methodsThis study included eyes with ERM-FS that underwent vitrectomy between April 2020 and November 2023 and were followed for at least 6 months. Eyes with ERM-FS alone were classified as the ERM-FS group, those with concomitant MPH as the ERM-FS+MPH group, and those with concomitant LMH as the ERM-FS+LMH group. Best-corrected visual acuity (BCVA) and OCT findings were evaluated before surgery and at 1, 3, and 6 months. OCT assessments included foveoschisis, inner retinal cysts, epiretinal proliferation (EP), and ellipsoid zone (EZ) disruption.
resultsFifty-nine eyes were included. BCVA improved significantly in the overall cohort and in each group. Patients in the ERM-FS+LMH group tended to have poorer visual outcomes than those in the ERM-FS and ERM-FS+MPH groups. Schisis gradually decreased after surgery in all groups. The ERM-FS+LMH group showed a higher prevalence of EP than the other groups and a significantly higher frequency of EZ disruption than the ERM-FS group. In the ERM-FS+LMH group, postoperative BCVA was associated with preoperative EZ disruption. Multivariate analysis identified preoperative BCVA as an independent predictor of postoperative BCVA.
conclusionsVitrectomy for ERM-FS improved visual acuity and retinal morphology in all groups. However, eyes with concomitant LMH tended to have poorer postoperative visual outcomes.
Indexed as
Identifiers
42828613What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.